SCHEMBL6933473

SCHEMBL6933473

CCC(CN(C)C)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28760081 0.87 TSHR (0.30)
SCHEMBL18508048 0.83
SCHEMBL18652870 0.81
SCHEMBL18508060 0.81
SCHEMBL18958979 0.79
SCHEMBL18958980 0.79
SCHEMBL18508049 0.79 DNM1 (0.31)
SCHEMBL18958981 0.79
SCHEMBL18508042 0.78 PLA2G1B (0.33)
SCHEMBL10136491 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223761-A1 QUINAZOLINE COMPOUND AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2023-08-09 EP disclosed
US-9994593-B2 Copper compound, starting material for forming thin film, and method for manufacturing thin film ADEKA CORPORATION (JP) 2018-06-12 US disclosed
US-20170044188-A1 COPPER COMPOUND, STARTING MATERIAL FOR FORMING THIN FILM, AND METHOD FOR MANUFACTURING THIN FILM ADEKA CORPORATION (JP) 2017-02-16 US disclosed
WO-2011114275-A1 SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES UNIVERSITY OF BASEL (CH) 2011-09-22 WO disclosed